Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells
Taewoo Kim,
Kyoung Il Min,
Jeong-Sun Yang,
Jun Won Kim,
Junhyung Cho,
Yun Ho Kim,
Jeong Seok Lee,
Young Tae Kim,
Kyung-Chang Kim,
Jeong Yeon Kim,
Kwon Joong Na,
Joo-Yeon Lee,
Young Seok Ju
Affiliations
Taewoo Kim
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea
Kyoung Il Min
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea
Jeong-Sun Yang
Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea
Jun Won Kim
Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea
Junhyung Cho
Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea
Yun Ho Kim
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul 03080, Republic of Korea
Jeong Seok Lee
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea; GENOME INSIGHT Inc., Daejeon 34051, Republic of Korea
Young Tae Kim
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul 03080, Republic of Korea
Kyung-Chang Kim
Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea
Jeong Yeon Kim
GENOME INSIGHT Inc., Daejeon 34051, Republic of Korea
Kwon Joong Na
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul 03080, Republic of Korea; Corresponding author
Joo-Yeon Lee
Division of Emerging Virus & Vector Research, Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea; Corresponding author
Young Seok Ju
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea; GENOME INSIGHT Inc., Daejeon 34051, Republic of Korea; Corresponding author
Summary: With the continuous emergence of highly transmissible SARS-CoV-2 variants, the comparison of their infectivity has become a critical issue for public health. However, a direct assessment of the viral characteristic has been challenging because of the lack of appropriate experimental models and efficient methods. Here, we integrated human alveolar organoids and single-cell transcriptome sequencing to facilitate the evaluation. In a proof-of-concept study with four highly transmissible SARS-CoV-2 variants, including GR (B.1.1.119), Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (BA.1), a rapid evaluation of the relative infectivity was possible. Our system demonstrates that the Omicron variant is 5- to 7-fold more infectious to human alveolar cells than the other SARS-CoV-2 variants at the initial stage of infection. To our knowledge, for the first time, this study measures the relative infectivity of the Omicron variant under multiple virus co-infection and provides new experimental procedures that can be applied to monitor emerging viral variants.